Juraporn Pongwecharak1, Tarakamon Treeranurat. 1. Department of Clinical Pharmacy, Faculty of Pharmaceutical Sciences, Prince of Songkla University, Hat Yai, Songkhla, 90112, Thailand. pjurapor@pharmacy.psu.ac.th
Abstract
OBJECTIVES: To identify subjects with pre-hypertension and elevated cardiovascular risk factors in a community pharmacy and to assess their readiness to adopt lifestyle changes. SETTING: An accredited community pharmacy in Songkla province, Thailand. METHOD: Subjects aged >or= 35 years old and reporting no hypertension or other cardiovascular disease were included. Blood pressure was measured using the Microlife BP 3AC1-1. Those with pre-hypertension or hypertension defined by the JNC 7, and reporting no diabetes and/or dyslipidemia, were checked for blood glucose and/or total cholesterol with the Accutrend GCT monitor. Other risk factors were collected. Their readiness to adopt healthy lifestyles was evaluated. MAIN OUTCOME MEASURE: The prevalence of pre-hypertension and elevated cardiovascular risk factors. RESULTS: 350 subjects met the study criteria. Approximately 36 and 29% were pre-hypertensive and hypertensive, respectively. Two of these had blood glucose > 200 mg/dl but about 47% had total cholesterol > 200 mg/dl. Most common modifiable cardiovascular risks were inadequate exercise and elevated body mass index (approximately 52% each). Almost 40% were ready to adopt healthy lifestyles within 1-6 months. CONCLUSION: Subjects at risk for hypertension and cardiovascular disease can be identified by community pharmacists, with the use of point-of-care devices and careful interview.
OBJECTIVES: To identify subjects with pre-hypertension and elevated cardiovascular risk factors in a community pharmacy and to assess their readiness to adopt lifestyle changes. SETTING: An accredited community pharmacy in Songkla province, Thailand. METHOD: Subjects aged >or= 35 years old and reporting no hypertension or other cardiovascular disease were included. Blood pressure was measured using the Microlife BP 3AC1-1. Those with pre-hypertension or hypertension defined by the JNC 7, and reporting no diabetes and/or dyslipidemia, were checked for blood glucose and/or total cholesterol with the Accutrend GCT monitor. Other risk factors were collected. Their readiness to adopt healthy lifestyles was evaluated. MAIN OUTCOME MEASURE: The prevalence of pre-hypertension and elevated cardiovascular risk factors. RESULTS: 350 subjects met the study criteria. Approximately 36 and 29% were pre-hypertensive and hypertensive, respectively. Two of these had blood glucose > 200 mg/dl but about 47% had total cholesterol > 200 mg/dl. Most common modifiable cardiovascular risks were inadequate exercise and elevated body mass index (approximately 52% each). Almost 40% were ready to adopt healthy lifestyles within 1-6 months. CONCLUSION: Subjects at risk for hypertension and cardiovascular disease can be identified by community pharmacists, with the use of point-of-care devices and careful interview.
Authors: Kathleen A Snella; Ann E Canales; Brian K Irons; Rebecca B Sleeper-Irons; Maumi C Villarreal; Valerie E Levi-Derrick; R Shane Greene; Jamie L Jolly; Arthur A Nelson Journal: J Am Pharm Assoc (2003) Date: 2006 May-Jun
Authors: Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella Journal: Hypertension Date: 2003-12-01 Impact factor: 10.190
Authors: S Kadowaki; T Okamura; A Hozawa; T Kadowaki; A Kadota; Y Murakami; K Nakamura; S Saitoh; Y Nakamura; T Hayakawa; Y Kita; A Okayama; H Ueshima Journal: Diabetologia Date: 2008-01-16 Impact factor: 10.122
Authors: James Hodgkinson; Constantinos Koshiaris; Una Martin; Jonathan Mant; Carl Heneghan; Fd Richard Hobbs; Richard J McManus Journal: Br J Gen Pract Date: 2016-03-29 Impact factor: 5.386
Authors: Nucharapon Liangruenrom; Kanyapat Suttikasem; Melinda Craike; Jason A Bennie; Stuart J H Biddle; Zeljko Pedisic Journal: BMC Public Health Date: 2018-06-14 Impact factor: 3.295
Authors: Jorge César Correia; Sarah Lachat; Grégoire Lagger; François Chappuis; Alain Golay; David Beran Journal: BMC Public Health Date: 2019-11-21 Impact factor: 3.295